AU8770282A - Composition for the treatment of atherosclerosis - Google Patents

Composition for the treatment of atherosclerosis

Info

Publication number
AU8770282A
AU8770282A AU87702/82A AU8770282A AU8770282A AU 8770282 A AU8770282 A AU 8770282A AU 87702/82 A AU87702/82 A AU 87702/82A AU 8770282 A AU8770282 A AU 8770282A AU 8770282 A AU8770282 A AU 8770282A
Authority
AU
Australia
Prior art keywords
atherosclerosis
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87702/82A
Other languages
English (en)
Inventor
Shaun R. Coughlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COUGHLIN S R
Original Assignee
COUGHLIN S R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COUGHLIN S R filed Critical COUGHLIN S R
Publication of AU8770282A publication Critical patent/AU8770282A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
AU87702/82A 1981-08-27 1982-08-25 Composition for the treatment of atherosclerosis Abandoned AU8770282A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29707681A 1981-08-27 1981-08-27
US297076 1981-08-27

Publications (1)

Publication Number Publication Date
AU8770282A true AU8770282A (en) 1983-03-03

Family

ID=23144754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87702/82A Abandoned AU8770282A (en) 1981-08-27 1982-08-25 Composition for the treatment of atherosclerosis

Country Status (7)

Country Link
JP (1) JPS5865224A (ja)
AU (1) AU8770282A (ja)
BE (1) BE894228A (ja)
DE (1) DE3232031A1 (ja)
FR (1) FR2511869A1 (ja)
GB (1) GB2105192A (ja)
IT (1) IT1153185B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233412B (it) * 1987-12-02 1992-03-30 Acraf Uso del trazodone
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE19900674A1 (de) * 1999-01-11 2000-07-13 Basf Ag Bindungspartner für 5-HT5-Rezeptoren zur Migränebehandlung
DE10043124A1 (de) 2000-08-31 2002-03-14 Max Delbrueck Centrum Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH553161A (de) * 1970-10-30 1974-08-30 Hoffmann La Roche Verfahren zur herstellung von phenylalaninderivaten.
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen

Also Published As

Publication number Publication date
GB2105192A (en) 1983-03-23
FR2511869A1 (fr) 1983-03-04
DE3232031A1 (de) 1983-05-05
JPS5865224A (ja) 1983-04-18
IT1153185B (it) 1987-01-14
IT8223020A0 (it) 1982-08-27
BE894228A (fr) 1982-12-16

Similar Documents

Publication Publication Date Title
AU555915B2 (en) Lipip compositions
AU546940B2 (en) Box-pleated diaper
AU3064184A (en) Improved compositions for the treatment of psoriasis
AU8146082A (en) Cleaning composition
AU561530B2 (en) Imidazoquinoxaline compounds
AU559903B2 (en) Diaper
AU562093B2 (en) Diaper
AU8420482A (en) Zwitter-cephem compounds
AU9117382A (en) Diaper
AU555773B2 (en) Coating composition
AU8030582A (en) Novel compounds
AU554085B2 (en) Heat treatment of materials
AU8770282A (en) Composition for the treatment of atherosclerosis
AU549367B2 (en) 5 fluro-pgi compounds
GB2110088B (en) Compositions for the treatment of acne
AU549271B2 (en) Levamisole composition
AU559888B2 (en) Diaper
AU8254082A (en) Diaper
AU8559582A (en) Titanium
AU7956482A (en) Lecithin-hydrogen peroxide composition
AU7997382A (en) Haemobiologic composition
DE3167587D1 (en) Composition for the treatment of acne
AU8605582A (en) Aminotriazolo-cephem compounds
AU543343B2 (en) Epoxy-imide composition
AU7172381A (en) Medicinal composition